Occupational Medicine, ISSN 0962-7480, 07/2015, Volume 65, Issue 5, pp. 348 - 356
Background Since the last In-Depth Review of lead toxicity in 2004 there have been further developments with regard to safe exposure levels for lead workers....
Organic lead | Toxicity | Legislation | Inorganic lead | toxicity | MORTALITY | RENAL-FUNCTION | SPERM COUNT | NEUROTOXICITY | PRESSURE | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | SMELTER WORKERS | SPONTANEOUS-ABORTION | DYSFUNCTION | organic lead | legislation | BLOOD-LEAD | OCCUPATIONAL-EXPOSURE | Lead Poisoning - prevention & control | Occupational Exposure - adverse effects | Occupational Health | Lead - toxicity | Humans | Occupational Diseases - etiology
Organic lead | Toxicity | Legislation | Inorganic lead | toxicity | MORTALITY | RENAL-FUNCTION | SPERM COUNT | NEUROTOXICITY | PRESSURE | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | SMELTER WORKERS | SPONTANEOUS-ABORTION | DYSFUNCTION | organic lead | legislation | BLOOD-LEAD | OCCUPATIONAL-EXPOSURE | Lead Poisoning - prevention & control | Occupational Exposure - adverse effects | Occupational Health | Lead - toxicity | Humans | Occupational Diseases - etiology
Journal Article
European Journal of Heart Failure, ISSN 1388-9842, 01/2017, Volume 19, Issue 1, pp. 9 - 42
cancer therapy | cardiotoxicity | ischaemia | European Society of Cardiology | arrhythmias | myocardial dysfunction | cardio-oncology | early detection | surveillance | chemotherapy | CARDIAC & CARDIOVASCULAR SYSTEMS | PULMONARY ARTERIAL-HYPERTENSION | TRANSIENT ISCHEMIC ATTACK | RENAL-CELL CARCINOMA | TYROSINE KINASE INHIBITORS | TRIAL COMPARING DOXORUBICIN | LEFT-VENTRICULAR DYSFUNCTION | ANTHRACYCLINE-INDUCED CARDIOMYOPATHY | METASTATIC BREAST-CANCER | ACUTE LYMPHOBLASTIC-LEUKEMIA | CONGESTIVE-HEART-FAILURE | Congresses as Topic | Societies, Medical | Antineoplastic Agents - adverse effects | Europe | Humans | Antineoplastic Agents - therapeutic use | Cardiotoxicity | Cardiology | Heart Diseases - chemically induced | Neoplasms - drug therapy | Practice Guidelines as Topic | Index Medicus | Life Sciences | Human health and pathology | Surgery | Cardiology and cardiovascular system
Journal Article
Archives of Toxicology, ISSN 0340-5761, 8/2012, Volume 86, Issue 8, pp. 1167 - 1231
Amphetamines represent a class of psychotropic compounds, widely abused for their stimulant, euphoric, anorectic, and, in some cases, emphathogenic,...
Oxidative stress | 3,4-Methylenedioxymethamphetamine | Environmental Health | Cardiovascular toxicity | Methamphetamine | Rhabdomyolysis | Biomedicine general | Neurotoxicity | Biomedicine | Amphetamine | Occupational Medicine/Industrial Medicine | Amphetamines | Pharmacology/Toxicology | Pharmacokinetics | Hyperthermia | Hepatotoxicity | Nephrotoxicity | INDUCED DOPAMINERGIC NEUROTOXICITY | METHAMPHETAMINE-INDUCED NEUROTOXICITY | ACUTE-RENAL-FAILURE | HUMAN LIVER-MICROSOMES | ISOLATED RAT HEPATOCYTES | MDMA-INDUCED HYPERTHERMIA | CATECHOL-O-METHYLTRANSFERASE | VESICULAR MONOAMINE TRANSPORTER | ACUTE MYOCARDIAL-INFARCTION | RECREATIONAL ECSTASY/MDMA USERS | TOXICOLOGY | Genetic Predisposition to Disease | Risk Assessment | Humans | Risk Factors | Amphetamine - chemistry | Central Nervous System Stimulants - toxicity | Neurotoxicity Syndromes - etiology | Animals | Central Nervous System Stimulants - pharmacokinetics | Kidney Diseases - chemically induced | Central Nervous System Stimulants - chemistry | Rhabdomyolysis - chemically induced | Amphetamine-Related Disorders - genetics | Amphetamine - toxicity | Heart Diseases - chemically induced | Amphetamine - pharmacokinetics | Amphetamine-Related Disorders - complications | Amphetamine-Related Disorders - metabolism | Chemical and Drug Induced Liver Injury - etiology | Index Medicus
Oxidative stress | 3,4-Methylenedioxymethamphetamine | Environmental Health | Cardiovascular toxicity | Methamphetamine | Rhabdomyolysis | Biomedicine general | Neurotoxicity | Biomedicine | Amphetamine | Occupational Medicine/Industrial Medicine | Amphetamines | Pharmacology/Toxicology | Pharmacokinetics | Hyperthermia | Hepatotoxicity | Nephrotoxicity | INDUCED DOPAMINERGIC NEUROTOXICITY | METHAMPHETAMINE-INDUCED NEUROTOXICITY | ACUTE-RENAL-FAILURE | HUMAN LIVER-MICROSOMES | ISOLATED RAT HEPATOCYTES | MDMA-INDUCED HYPERTHERMIA | CATECHOL-O-METHYLTRANSFERASE | VESICULAR MONOAMINE TRANSPORTER | ACUTE MYOCARDIAL-INFARCTION | RECREATIONAL ECSTASY/MDMA USERS | TOXICOLOGY | Genetic Predisposition to Disease | Risk Assessment | Humans | Risk Factors | Amphetamine - chemistry | Central Nervous System Stimulants - toxicity | Neurotoxicity Syndromes - etiology | Animals | Central Nervous System Stimulants - pharmacokinetics | Kidney Diseases - chemically induced | Central Nervous System Stimulants - chemistry | Rhabdomyolysis - chemically induced | Amphetamine-Related Disorders - genetics | Amphetamine - toxicity | Heart Diseases - chemically induced | Amphetamine - pharmacokinetics | Amphetamine-Related Disorders - complications | Amphetamine-Related Disorders - metabolism | Chemical and Drug Induced Liver Injury - etiology | Index Medicus
Journal Article
Magnetic Resonance Imaging, ISSN 0730-725X, 2016, Volume 34, Issue 10, pp. 1394 - 1398
Abstract GBCAs play an important role in the diagnostic evaluation of many patients. The safety of these agents has been once again questioned after gadolinium...
Radiology | Gadolinium deposition disease | Gadolinium | Treatment | Adverse events | Toxicity | HEALTHY RATS DIFFERENCE | HIGH-SIGNAL INTENSITY | CONTRAST AGENTS | GLOBUS-PALLIDUS | NORMAL RENAL-FUNCTION | DEEP CEREBELLAR NUCLEI | T1-WEIGHTED MR-IMAGES | DENTATE NUCLEUS | HUMAN BONE TISSUE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | NEPHROGENIC SYSTEMIC FIBROSIS | Bone Diseases - chemically induced | Bone Diseases - therapy | Humans | Nephrogenic Fibrosing Dermopathy - chemically induced | Nephrogenic Fibrosing Dermopathy - therapy | Gadolinium - adverse effects | Joint Diseases - chemically induced | Joint Diseases - therapy | Bone and Bones - drug effects | Brain Diseases - chemically induced | Drug Hypersensitivity - therapy | Brain - drug effects | Brain - metabolism | Contrast Media - adverse effects | Brain Diseases - therapy | Bone and Bones - metabolism | Gadolinium - metabolism | Index Medicus
Radiology | Gadolinium deposition disease | Gadolinium | Treatment | Adverse events | Toxicity | HEALTHY RATS DIFFERENCE | HIGH-SIGNAL INTENSITY | CONTRAST AGENTS | GLOBUS-PALLIDUS | NORMAL RENAL-FUNCTION | DEEP CEREBELLAR NUCLEI | T1-WEIGHTED MR-IMAGES | DENTATE NUCLEUS | HUMAN BONE TISSUE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | NEPHROGENIC SYSTEMIC FIBROSIS | Bone Diseases - chemically induced | Bone Diseases - therapy | Humans | Nephrogenic Fibrosing Dermopathy - chemically induced | Nephrogenic Fibrosing Dermopathy - therapy | Gadolinium - adverse effects | Joint Diseases - chemically induced | Joint Diseases - therapy | Bone and Bones - drug effects | Brain Diseases - chemically induced | Drug Hypersensitivity - therapy | Brain - drug effects | Brain - metabolism | Contrast Media - adverse effects | Brain Diseases - therapy | Bone and Bones - metabolism | Gadolinium - metabolism | Index Medicus
Journal Article
Advances in Chronic Kidney Disease, ISSN 1548-5595, 05/2017, Volume 24, Issue 3, pp. 138 - 146
Until 2006, the main considerations regarding safety for all gadolinium-based contrast agents (GBCAs) were related to shortterm adverse reactions. However, the...
Gadolinium deposition disease | Gadolinium-based contrast agents | Gadolinium storage condition | Toxicity | CONTRAST AGENTS | GLOBUS-PALLIDUS | NORMAL RENAL-FUNCTION | BLOOD-BRAIN-BARRIER | T1-WEIGHTED MR-IMAGES | DENTATE NUCLEUS | HUMAN BONE TISSUE | PLASMA-MASS SPECTROSCOPY | UROLOGY & NEPHROLOGY | HIGH SIGNAL INTENSITY | NEPHROGENIC SYSTEMIC FIBROSIS | Skin Diseases - chemically induced | Gadolinium - pharmacokinetics | Humans | Contrast Media - pharmacokinetics | Gadolinium - adverse effects | Pain - chemically induced | Renal Insufficiency, Chronic - complications | Gadolinium - chemistry | Brain - metabolism | Magnetic Resonance Imaging | Contrast Media - adverse effects | Contrast Media - metabolism | Contrast Media - chemistry | Cognitive Dysfunction - chemically induced | Gadolinium - metabolism
Gadolinium deposition disease | Gadolinium-based contrast agents | Gadolinium storage condition | Toxicity | CONTRAST AGENTS | GLOBUS-PALLIDUS | NORMAL RENAL-FUNCTION | BLOOD-BRAIN-BARRIER | T1-WEIGHTED MR-IMAGES | DENTATE NUCLEUS | HUMAN BONE TISSUE | PLASMA-MASS SPECTROSCOPY | UROLOGY & NEPHROLOGY | HIGH SIGNAL INTENSITY | NEPHROGENIC SYSTEMIC FIBROSIS | Skin Diseases - chemically induced | Gadolinium - pharmacokinetics | Humans | Contrast Media - pharmacokinetics | Gadolinium - adverse effects | Pain - chemically induced | Renal Insufficiency, Chronic - complications | Gadolinium - chemistry | Brain - metabolism | Magnetic Resonance Imaging | Contrast Media - adverse effects | Contrast Media - metabolism | Contrast Media - chemistry | Cognitive Dysfunction - chemically induced | Gadolinium - metabolism
Journal Article
Clinical Toxicology, ISSN 1556-3650, 06/2014, Volume 52, Issue 5, pp. 479 - 489
Abstract Context. Clinical effects of hydrocarbon exposure have been reported since 1897. These substances are ubiquitous, and their exposures are common. The...
Delirium | Aspiration pneumonitis | Inhalant abuse | Sudden sniffing death | Toluene | LIPOID PNEUMONIA | NATIONAL EPIDEMIOLOGIC SURVEY | SOLVENT-INDUCED ENCEPHALOPATHY | VOLATILE SUBSTANCE ABUSE | CLINICAL TOXICOLOGY | KEROSENE ASPIRATION | CARDIAC SENSITIZATION | TOXICOLOGY | RENAL TUBULAR-ACIDOSIS | ABUSED INHALANT TOLUENE | METHYL-D-ASPARTATE | Substance-Related Disorders - etiology | Administration, Oral | Humans | Administration, Inhalation | Pneumonia, Aspiration - chemically induced | Hydrocarbons - toxicity | Administration, Cutaneous | Substance-Related Disorders - complications | Solvents - toxicity | Hydrocarbons - administration & dosage | Animals | Inhalant Abuse - complications | Solvents - administration & dosage | Child | Pneumonia, Aspiration - physiopathology | Solvent abuse | Complications and side effects | Aspiration pneumonia | Patient outcomes | Hydrocarbons | Poisoning | Research | Health aspects | Risk factors
Delirium | Aspiration pneumonitis | Inhalant abuse | Sudden sniffing death | Toluene | LIPOID PNEUMONIA | NATIONAL EPIDEMIOLOGIC SURVEY | SOLVENT-INDUCED ENCEPHALOPATHY | VOLATILE SUBSTANCE ABUSE | CLINICAL TOXICOLOGY | KEROSENE ASPIRATION | CARDIAC SENSITIZATION | TOXICOLOGY | RENAL TUBULAR-ACIDOSIS | ABUSED INHALANT TOLUENE | METHYL-D-ASPARTATE | Substance-Related Disorders - etiology | Administration, Oral | Humans | Administration, Inhalation | Pneumonia, Aspiration - chemically induced | Hydrocarbons - toxicity | Administration, Cutaneous | Substance-Related Disorders - complications | Solvents - toxicity | Hydrocarbons - administration & dosage | Animals | Inhalant Abuse - complications | Solvents - administration & dosage | Child | Pneumonia, Aspiration - physiopathology | Solvent abuse | Complications and side effects | Aspiration pneumonia | Patient outcomes | Hydrocarbons | Poisoning | Research | Health aspects | Risk factors
Journal Article